[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@julialmv](/creator/twitter/julialmv) "LoCITT-T is a 1000-person double-blind randomized placebo-controlled trial. This trial has been designed in partnership with patients (not just me) throughout. e.g. most Long COVID clinical trials that have released results have not resulted in the improvement. 2/16" [X Link](https://x.com/julialmv/status/1983968187449536719) [@julialmv](/creator/x/julialmv) 2025-10-30T18:44Z 2015 followers, 1684 engagements "We expect there to be varied responses within people with Long COVID and have aimed to power the trial accordingly by enrolling a large number of participants & asking a lot of questions that will allow us to analyze subgroups of participants. 11/16" [X Link](https://x.com/julialmv/status/1983968202834243968) [@julialmv](/creator/x/julialmv) 2025-10-30T18:44Z 2014 followers, XXX engagements "We have been working with @careevolution to create a platform for digital clinical trials that allows participants across the US to participate from wherever they are. There are many drugs we would like to test & we are pursuing the funding to support more trials. 12/16" [X Link](https://x.com/julialmv/status/1983968204423880836) [@julialmv](/creator/x/julialmv) 2025-10-30T18:44Z 2014 followers, XXX engagements "my wonderful colleagues who conquered all the setbacks we encountered (especially @EricTopol who I am co-leading the trial with) our knowledgeable data safety monitoring board members & most of all the participants who decide to spend their precious energy on this trial. 15/16" [X Link](https://x.com/julialmv/status/1983968210463740201) [@julialmv](/creator/x/julialmv) 2025-10-30T18:44Z 2014 followers, XXX engagements "The Long COVID Treatment Trial Tirzepatide (LoCITT-T) is officially open for enrollment for people with Long COVID in: Alabama Alaska California Florida Illinois Indiana Michigan Ohio Pennsylvania Texas Utah 1/16" [X Link](https://x.com/julialmv/status/1983968185444659385) [@julialmv](/creator/x/julialmv) 2025-10-30T18:44Z 2015 followers, 67.8K engagements "while including secondary endpoints (like FUNCAP & step count from wearables) that we expect to be more sensitive & will learn more about. Weve made efforts to make the trial accessible to people who are unable to verbally speak due to the severity of their illness 4/16" [X Link](https://x.com/julialmv/status/1983968190657962265) [@julialmv](/creator/x/julialmv) 2025-10-30T18:44Z 2014 followers, XXX engagements ". by having people who require this accommodation test the experience. It has taken a lot to get to this point with difficult tradeoffs along the way. I am confident weve done our best within our constraints & that well improve as we learn from participants. 5/16" [X Link](https://x.com/julialmv/status/1983968192528810244) [@julialmv](/creator/x/julialmv) 2025-10-30T18:44Z 2015 followers, XXX engagements "To learn more register for our webinar on 11/5: Read the op-ed I wrote about this study & the need for at-home trials in The Sick TImes: Read our press release: grateful & hopeful JMV 16/16" [X Link](https://x.com/julialmv/status/1983968212183347343) [@julialmv](/creator/x/julialmv) 2025-10-30T18:44Z 2015 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@julialmv
"LoCITT-T is a 1000-person double-blind randomized placebo-controlled trial. This trial has been designed in partnership with patients (not just me) throughout. e.g. most Long COVID clinical trials that have released results have not resulted in the improvement. 2/16"
X Link @julialmv 2025-10-30T18:44Z 2015 followers, 1684 engagements
"We expect there to be varied responses within people with Long COVID and have aimed to power the trial accordingly by enrolling a large number of participants & asking a lot of questions that will allow us to analyze subgroups of participants. 11/16"
X Link @julialmv 2025-10-30T18:44Z 2014 followers, XXX engagements
"We have been working with @careevolution to create a platform for digital clinical trials that allows participants across the US to participate from wherever they are. There are many drugs we would like to test & we are pursuing the funding to support more trials. 12/16"
X Link @julialmv 2025-10-30T18:44Z 2014 followers, XXX engagements
"my wonderful colleagues who conquered all the setbacks we encountered (especially @EricTopol who I am co-leading the trial with) our knowledgeable data safety monitoring board members & most of all the participants who decide to spend their precious energy on this trial. 15/16"
X Link @julialmv 2025-10-30T18:44Z 2014 followers, XXX engagements
"The Long COVID Treatment Trial Tirzepatide (LoCITT-T) is officially open for enrollment for people with Long COVID in: Alabama Alaska California Florida Illinois Indiana Michigan Ohio Pennsylvania Texas Utah 1/16"
X Link @julialmv 2025-10-30T18:44Z 2015 followers, 67.8K engagements
"while including secondary endpoints (like FUNCAP & step count from wearables) that we expect to be more sensitive & will learn more about. Weve made efforts to make the trial accessible to people who are unable to verbally speak due to the severity of their illness 4/16"
X Link @julialmv 2025-10-30T18:44Z 2014 followers, XXX engagements
". by having people who require this accommodation test the experience. It has taken a lot to get to this point with difficult tradeoffs along the way. I am confident weve done our best within our constraints & that well improve as we learn from participants. 5/16"
X Link @julialmv 2025-10-30T18:44Z 2015 followers, XXX engagements
"To learn more register for our webinar on 11/5: Read the op-ed I wrote about this study & the need for at-home trials in The Sick TImes: Read our press release: grateful & hopeful JMV 16/16"
X Link @julialmv 2025-10-30T18:44Z 2015 followers, XXX engagements
/creator/twitter::2292764749/posts